Clinical trial Recruiting at 1 site Observational Ages 18 to 70 Women only

Fibrin clot structure and thrombin production after urogynecological surgery

Official title: Fibrin Clot Properties and Thrombin Generation in Women After Urogynecological Surgery.

Run by Jagiellonian University · NCT07295782 · Data updated 2026-11-12

This project will test whether blood fibrin clot properties and thrombin generation change in women after surgery for uterine prolapse or urinary incontinence.

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexWomen only
Enrollment60 (estimated)
SponsorJagiellonian University
Academic / other
Locations1 site (Krakow, Małopolska)
StatusRecruiting
StartedDecember 10, 2025
Main results expectedMay 30, 2026
Study endsMay 30, 2026
Registry record updatedDecember 22, 2025
Trial IDNCT07295782 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–70 having surgery for uterine prolapse or urinary incontinence after pharmacologic treatment failure, without known congenital or acquired thrombophilia, are ideal candidates.

Probably not a fit

Patients with known thrombophilia, those on prolonged thromboprophylaxis, or those undergoing other planned surgeries are unlikely to benefit from the study's specific findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project measures blood fibrin clot properties and thrombin generation in women after urogynecological surgery for uterine prolapse or urinary incontinence. Blood samples will be analyzed for clot permeability, susceptibility to fibrinolysis, and thrombin generation assays. Eligible participants are women aged 18–70 who undergo surgery after pharmacologic treatment failure, excluding those with congenital or acquired thrombophilia or prolonged thromboprophylaxis. No investigational treatments are given; clinical data and laboratory measurements will be correlated to characterize postoperative clotting phenotypes.

Why it matters

Potential benefit: If successful, the findings could help identify women at higher postoperative clotting risk and guide more personalized thromboprophylaxis.

How similar studies have gone: Clot-phenotype and thrombin generation measurements have been informative in thrombosis research broadly, but applying these assays specifically after urogynecological surgery is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-70
* treatment failure (pharmacotherapy) due to uterine prolapse or urine incontinence

Exclusion Criteria:

* prolonged thromboprophylaxis
* planned surgery other than due to urine incontinence/uterine prolapse
* acquired or congenital thrombophilia

Where it's running

  • Gynecological Endocrinology Department
    Krakow, Małopolska, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.